Childlore thrives when two conditions are met. One is a murkiness of origins. Nobody knows who first folded a cootie catcher or drew a “cool S.” Some childlore feels like it has always existed, ...
Gilead Sciences has agreed to acquire Forty Seven for $4.9 billion cash, the companies said today, in a deal intended to boost the buyer’s immuno-oncology R&D pipeline—anchored by Forty Seven’s lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results